P

Inventor

KLEIN J PETER

US50 patents
⚠️ This page may combine multiple inventors who share the name “KLEIN J PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELL THERAPEUTICS INC

49 patents
US5780476AJul 14, 1998

Hydroxyl-containing xanthine compounds

CELL THERAPEUTICS INC95 citations98
US5807861ASep 15, 1998

Amine substituted xanthinyl compounds

CELL THERAPEUTICS INC106 citations97
US5804584ASep 8, 1998

Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms

CELL THERAPEUTICS INC39 citations96
US5641783AJun 24, 1997

Substituted amino alcohol compounds

CELL THERAPEUTICS INC57 citations96
US5470878ANov 28, 1995

Cell signaling inhibitors

CELL THERAPEUTICS INC74 citations96
US5817662AOct 6, 1998

Substituted amino alkyl compounds

CELL THERAPEUTICS INC47 citations95
US5807862ASep 15, 1998

Therapeutic compounds containing pyrimidinyl moieties

CELL THERAPEUTICS INC53 citations95
US5340813AAug 23, 1994

Substituted aminoalkyl xanthine compounds

CELL THERAPEUTICS INC52 citations95
US7208507B2Apr 24, 2007

Pyridines and uses thereof

CELL THERAPEUTICS INC22 citations93
US6875781B2Apr 5, 2005

Pyridines and uses thereof

CELL THERAPEUTICS INC34 citations93
US7618968B2Nov 17, 2009

Aryl triazines as LPAAT-β inhibitors and uses thereof

CELL THERAPEUTICS INC24 citations92
US7291616B2Nov 6, 2007

Aryl triazines as LPAAT-β inhibitors and uses thereof

CELL THERAPEUTICS INC26 citations92
US6878715B1Apr 12, 2005

Therapeutic compounds for inhibiting interleukin-12 signals and method for using same

CELL THERAPEUTICS INC46 citations92
US6774130B2Aug 10, 2004

Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same

CELL THERAPEUTICS INC22 citations92
US6469017B1Oct 22, 2002

Method of inhibiting interleukin-12 signaling

CELL THERAPEUTICS INC17 citations92
US6133274AOct 17, 2000

Hydroxyl-containing bicyclic compounds

CELL THERAPEUTICS INC26 citations92
US6020337AFeb 1, 2000

Electronegative-substituted long chain xanthine compounds

CELL THERAPEUTICS INC36 citations92
US5837703ANov 17, 1998

Amino-alcohol substituted cyclic compounds

CELL THERAPEUTICS INC33 citations92
US5801181ASep 1, 1998

Amino alcohol substituted cyclic compounds

CELL THERAPEUTICS INC38 citations92
US5770595AJun 23, 1998

Oxime substituted therapeutic compounds

CELL THERAPEUTICS INC40 citations92
US5629423AMay 13, 1997

Asymmetric synthesis of chiral secondary alcohols

CELL THERAPEUTICS INC21 citations92
US5288721AFeb 22, 1994

Substituted epoxyalkyl xanthines

CELL THERAPEUTICS INC31 citations92
US5801182ASep 1, 1998

Amine substituted compounds

CELL THERAPEUTICS INC50 citations91
US7419984B2Sep 2, 2008

Pyrimidines and uses thereof

CELL THERAPEUTICS INC26 citations90
US5756511AMay 26, 1998

Method for treating symptoms of a neurodegenerative condition

CELL THERAPEUTICS INC19 citations84
US5777117AJul 7, 1998

Method for preparing substituted amino alcohol compounds

CELL THERAPEUTICS INC15 citations82
US5866576AFeb 2, 1999

Epoxide-containing compounds

CELL THERAPEUTICS INC15 citations81
US6075029AJun 13, 2000

Xanthine modulators of metabolism of cellular P-450

CELL THERAPEUTICS INC12 citations74
US5750575AMay 12, 1998

Substituted amino alcohol compounds

CELL THERAPEUTICS INC4 citations74
US6693105B1Feb 17, 2004

Hydroxyl-containing compounds

CELL THERAPEUTICS INC11 citations73
US6586429B2Jul 1, 2003

Tricyclic fused xanthine compounds and their uses

CELL THERAPEUTICS INC6 citations73
US6100271AAug 8, 2000

Therapeutic compounds containing xanthinyl

CELL THERAPEUTICS INC12 citations73
US6043250AMar 28, 2000

Methods for using therapeutic compounds containing xanthinyl

CELL THERAPEUTICS INC12 citations73
US5889011AMar 30, 1999

Substituted amino alkyl compounds

CELL THERAPEUTICS INC14 citations73
US5473070ADec 5, 1995

Substituted long chain alcohol xanthine compounds

CELL THERAPEUTICS INC18 citations73
US5354756AOct 11, 1994

Olefin-substituted long chain xanthine compounds

CELL THERAPEUTICS INC12 citations73
US6103730AAug 15, 2000

Amine substituted compounds

CELL THERAPEUTICS INC13 citations72
US7153864B2Dec 26, 2006

Polyglutamic acid-camptothecin conjugates and methods of preparation

CELL THERAPEUTICS INC10 citations71
US6780865B1Aug 24, 2004

Compounds having selective hydrolytic potentials

CELL THERAPEUTICS INC12 citations71
US5824677AOct 20, 1998

Substituted amino alcohol compounds

CELL THERAPEUTICS INC1 citations63
US6121270ASep 19, 2000

Epoxide-containing compounds

CELL THERAPEUTICS INC3 citations62
US5521315AMay 28, 1996

Olefin substituted long chain compounds

CELL THERAPEUTICS INC5 citations61
US7608620B2Oct 27, 2009

LPAAT-β inhibitors and uses thereof

CELL THERAPEUTICS INC1 citations58
US7399860B2Jul 15, 2008

Manufacture of polyglutamate-therapeutic agent conjugates

CELL THERAPEUTICS INC4 citations58
US7064125B2Jun 20, 2006

LPAAT-β inhibitors and uses thereof

CELL THERAPEUTICS INC2 citations58
US7247630B2Jul 24, 2007

Uses of tricyclic compounds

CELL THERAPEUTICS INC0 citations51
US7173041B2Feb 6, 2007

Polyglutamic acid-camptothecin conjugates and methods of preparation

CELL THERAPEUTICS INC0 citations50
US7053096B2May 30, 2006

Compounds having selective hydrolytic potentials

CELL THERAPEUTICS INC1 citations50
US6825180B2Nov 30, 2004

Pyridopyrimidine compounds and their uses

CELL THERAPEUTICS INC1 citations47

CELL THERAPUETICS INC

1 patent